AstraZeneca and Oxford Say Vaccine Is Up to 90 Percent Effective November 25, 2020 Auto Bot AstraZeneca PLC, Clinical Trials, Coronavirus (2019-nCoV), Coronavirus Risks and Safety Concerns, Oxford University, Vaccination and Immunization 0 In an early analysis, the drug maker zeroed in on a promising dosing plan for its vaccine.